Abstract:
본 발명은 하기 일반식(I)의 2,4-피리미딘디온 유도체 및 그의 약제학적으로 허용되는 염, 이의 제조방법 및 이를 유효성분으로 함유하는 항바이러스제 조성물에 관한 것으로, 일반식(I)의 화합물은 바이러스, 특히 HIV-1에 대한 선택도 및 생리활성도가 우수하고 독성이 낮아서 후천성 면역결핍증(AIDS) 치료제로 유용하다. (I) 상기식에서, R 1 은 C 1 -C 10 의 알콕시메틸, C 1 -C 10 의 알케닐메틸, C 1 -C 10 의 알킬, C 1 -C 10 의 알키닐메틸 또는 C 1 -C 10 의 알콕시카르보닐메틸이고; R 2 는 수소, 할로겐, C 1 -C 6 의 알킬, C 3 -C 6 의 시클로알킬, C 2 -C 8 의 알케닐, C 2 -C 8 의 알키닐 또는 벤질이고; R 3 및 R 4 는 각각 독립적으로 수소, 할로겐, 히드록시, 아지도, 아미노, C 1 -C 3 의 알킬, 불소화알킬, C 1 -C 8 의 알콕시, C 2 -C 8 의 알케닐, C 2 -C 8 의 알키닐 또는 벤질이고; X는 할로겐, 아지도, 시아노, 아미노, C 1 -C 4 의 알킬에스테르, C 1 -C 10 의 알킬아미드 또는 C 1 -C 20 의 알콕시이다.
Abstract:
PURPOSE: Provided are a novel antiviral 2,4-pyrimidinone derivative, its pharmaceutically acceptable salt, a method for manufacturing the same and an antiviral composition containing it as an active ingredient. The 2,4-pyrimidinone derivative is excellent in HIV-1 selectivity and physiological activity, and has low toxicity. Therefore, it is useful as the therapeutics for AIDS. CONSTITUTION: A novel 2,4-pyrimidinone derivative is represented by the formula(I), wherein R1 is C1-10 alkoxymethyl; R2 is hydrogen or C1-6 alkyl; R3 and R4 are independently hydrogen, halogen, C1-3 alkyl or fluorinated alkyl; and X is halogen, azido, cyano or C1-10 alkoxy. It is manufactured by the steps of; reacting a compound of the formula(II) with hexamethyldisilaxane to give a compound of the formula(III), and coupling the compound of the formula(III) with a compound of the formula(IV).
Abstract:
PURPOSE: Provided are 2,4-pyrimidinedione derivatives which are excellent in selectivity and bioactivity for wild type and mutant HIV-1 and have low toxicity, therefore which can be used for treating AIDS. CONSTITUTION: The 2,4-pyrimidinedione derivatives represented by the formula I are prepared by coupling two compounds represented by the formulas II and III, wherein R1 is phenyl, pyridyl, methyl, amino, nitro, methoxy, trifluoromethyl, and etc., R2 is ethyl, isopropyl, etc., R3 and R4 is independently hydrogen, fluorine, chlorine, methyl, fluoromethyl, nitro, etc., A is oxygen or sulfur, Z is oxygen, sulfur, C=O, NH, or CH2, Z' is equal to the Z but Z' is acetamido if A is oxygen, Y is halogen, methane sulfonyl, toluene sulfonyl, or trifluoromethane sulfonyl.
Abstract:
PURPOSE: Provided are 2,4-pyrimidinedione derivatives which are excellent in selectivity and bioactivity for wild type and mutant HIV-1 and have low toxicity, therefore which can be used for treating AIDS. CONSTITUTION: The 2,4-pyrimidinedione derivatives represented by the formula I are prepared by coupling two compounds represented by the formulas II and III, wherein R1 is phenyl, pyridyl, methyl, amino, nitro, methoxy, trifluoromethyl, and etc., R2 is ethyl, isopropyl, etc., R3 and R4 is independently hydrogen, fluorine, chlorine, methyl, fluoromethyl, nitro, etc., A is oxygen or sulfur, Z is oxygen, sulfur, C=O, NH, or CH2, Z' is equal to the Z but Z' is acetamido if A is oxygen, Y is halogen, methane sulfonyl, toluene sulfonyl, or trifluoromethane sulfonyl.